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 1 
Introduction 
Background 
 In the United States alone, more than one million people are blind (1). 
More than 3.4 million people age forty and over are visually impaired, and over 
11 million individuals age 12 and older suffer from visual impairments (2). More 
than 14 million people in the U.S. and 135 million worldwide have low vision  
(3). 
The leading causes of these sight-threatening diseases are Diabetic 
Retinopathy, Age-related Muscular Degeneration (AMD), Retinitis Pigmentosa 
and Glaucoma (4). Diabetic Retinopathy is caused by damage of blood vessels of 
the retina and is the leading cause of blindness in working age Americans, 
affecting more than 5.3 million Americans above the age of 18 (4). Age- related 
Muscular Degeneration is a condition that primarily affects the part of the retina 
responsible for sharp central vision. AMD is the most common cause of legal 
blindness and vision impairments in older Americans, plaguing about 1.6 million 
Americans over the age of 60 (4). Glaucoma is a chronic condition marked by 
gradual damage to the optic nerve that carries visual information from the eye to 
the brain (4). Retinitis Pigmentosa results from the death of photoreceptor cells, 
which leads to the decline of vision (4). All of these diseases result from the death 
of one or more retinal cell type. Currently, there is no cure for blinding diseases 
caused by retina cell death.  
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The Vertebrate Retina 
 
The vertebrate retina is the light sensitive tissue lining the inner surface of 
the eye. The retina receives image seen through the eye and it is responsible for 
transmitting this information through optical nerves to the brain (5). The retina is 
comprised of many cells, including the two types of photoreceptors, rods and 
cones. Rods are very sensitive to low light conditions and able to respond to a 
single photon of light; they are responsible for vision under low light conditions 
and also periphery vision. Rods are concentrated on the outer edges of the retina, 
and on average there are about 90 million rods in the retina (7). On the other hand, 
cones require more light for functioning and they provide information about color 
in very sharp detail. Cone cells are concentrated around the retina’s center. On 
average there are about 4.5 million cone cells in the retina. In humans, it is known 
that the loss of rod photoreceptors leads to degeneration of cones, and one of the 
commonly known disease in which this concept is manifested is Retinitis 
Pigmentosa. Approximately 100,000 people in the United States and 1.5 people 
worldwide are affected by Retinitis Pigmentosa, and there is no cure. 
 Retinitis pigmentosa (RP) is a heterogeneous group of inherited disorders 
characterized by the initial loss of rod photoreceptors (7). Since rod 
photoreceptors are finely tuned to detect low-light levels, rod cell death results in 
night-blindness, leaving daylight vision intact. Much more devastating to patients 
are the secondary degenerative changes resulting from rod loss, such as Müller 
glial cell hypertrophy, loss of synaptic layers, the death of interneurons and, most 
notably, subsequent death of the cone photoreceptors (Figure 1). Although cones 
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represent no more than 5% of all photoreceptors in the human eye, their role in 
vision is crucial. Cones are required for color vision, and their death leads to 
daylight vision loss and ultimately complete blindness (8). Uncoupling the 
cellular and molecular mechanisms that link rod cell loss to cone death would 
allow cones to survive and patients afflicted with Retinitis Pigmentosa to retain 
functional vision. 
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Figure 1. 
Model of retina degeneration. This diagram shows the stages of retina 
degeneration. The normal retina has both rod and cone photoreceptors and Müller 
glial cells intact. (Stage 1) represents the death of rod photoreceptors, which is 
followed by secondary changes, including cone degeneration (stage 2), reactive 
gliosis in the form of Müller cell hypertrophy (stage 3) and eventually the death 
of inner nuclear cells (late stage 3). 
 
 
 
 
 
Credit: Dr. Andrea Viczian  
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Mammalian animal models that mimic aspects of Retinitis Pigmentosa 
have been critical for investigating the mechanisms of rod cell death, and the 
subsequent cone degeneration. Xenopus laevis has been used in the field of 
developmental biology for a long time.  Awide variety of molecular biology 
techniques have been developed for this model organism, and many of the genes 
have been identified. Also, it is easy to obtain and maintain large numbers of 
Xenopus tadpoles in the laboratory. The Zuber lab recently developed a model of 
Retinitis Pigmentosa in the African Clawed Frog, Xenopus laevis (9) to examine 
whether Xenopus laevis will exhibit the same secondary cellular changes after rod 
ablation. To answer this question, Rene Choi generated a transgenic line of 
Xenopus laevis, driving the expression of E. Coli nitroreductase (NTR) under the 
control of the rod-specific rhodopsin promoter (XOP).  Nitroreductase converts 
nitromidazole prodrugs, such as metronidazole (Mtz), into a cytotoxic DNA 
crosslinker. Using this drug, Choi and colleagues (9) demonstrated that apoptotic 
rods were detected at 24 hours and rod outer segment degeneration was extensive 
by five days in Mtz- treated XOPNTR transgenic tadpoles (Figure 2). Also, cone 
photoreceptor degeneration and death followed rod ablation (Figure 3).  
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 Figure 2. 
Rod Ablation in XOPNTR Tadpoles  
Transgenic (A-C) tadpoles were treated for 5 days with DMSO only (A) or for 5 
or 10 days with Mtz (B and C). Retinal sections were stained with rod specific 
marker. In comparison to untreated transgenic tadpoles, a clear outer segment was 
observed in animals treated for as little as 5 days, and by 10 days of treatment the 
only observable rod outer segments was in the most peripheral retina.  
 
 
 
 
Credit: Rene Choi 
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Figure 3. 
 Cone Degenerate after Rod Ablation. 
 Stage 52 XOPNTR tadpoles were treated with Mtz for 1 to 17 days. Rapid rod 
cell loss was observed. The number of cones reduced gradually but significantly, 
indicating cone degeneration and pending cone cell death. 
 
 
Credit: Rene Choi 
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 The progressive loss of cones following the initial rapid period of rod 
photoreceptor death raises the possibility of rod-cone interactions playing a vital 
role in photoreceptor development and survival. Three possible mechanisms have 
been proposed to account for consequent cone loss (10).  The first postulation 
indicates that rod breakdown adversely affects neighboring cones by exposing 
outer segments of cones to toxic chemicals that may be released from rod death. 
However, rods die by apoptosis, which normally avoids the release of toxic 
cellular metabolites that would poison cones, or cause inflammation, and lead to 
cone death. A second explanation proposes that oxidative stress is one of the 
causes of cone death. This mechanism states that the high metabolic rate of 
photoreceptors is an intrinsic risk factor for oxidative damage, especially for 
cones, which contain twice as many mitochondrial as rods. Therefore, when rods 
are damaged, it results in greater than 90% photoreceptor loss, leaving few 
photoreceptors (cones which represent 5% of photoreceptors) to consume the 
majority of the oxygen. It is said that this high oxygen concentration may be toxic 
for cones, leading to death (11). However in the Xenopus retina, there are equal 
numbers of rods and cones, making this mechanism the unlikely cause of cone 
death.  Thirdly, it is hypothesized that rods produce some kind of signal that is 
essential for maintaining cone viability and the disappearance of rods deprives 
cones of this signal and triggers their degeneration. This third mechanism has 
gained significant traction with the discovery of Rod-derived Cone Viability 
Factor-1 (RdCVF1) in the laboratory of Dr. Thiery Léveillard (12). 
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RdCVF1 is a protein known to maintain the function and viability of cone 
photoreceptor cells in the retina. Nucleoredoxin like1 (Nxnl1) gene,a protein 
involved in the defense mechanism against oxidative stress, encodes RdCVF1 
(13). In mice, alternative splicing of this gene generates two products. One is 
RdCVF1-L, a full-length protein composed of 217 amino acid sequences. This 
protein has a putative thioredoxin (enzyme involved in defense against oxidative 
stress) activity. The second product is C-terminal post-transcriptionally truncated 
protein, with 109 amino acid sequences. This latter form serves as a trophic 
factor. Chalmel and colleagues (14) identified RdCVF-2, a protein encoded by the 
Nuclearedoxin-Like 2 (NXL2) gene. Alternative splicing also produce a long form, 
RdCVF2-L, with putative thioredoxin enzyme activity, and short form, RdCVF2, 
with cone survival factors.  
 Both the RdCVF1 and RdCVF2 proteins have distinct features; there is a 
“cap” region, which is the C-terminal region present in RdCVF1/2-Lbut absent in 
RdCVF1/2-S, and this portion of the protein gives the long isoforms a putative 
thio-oxyreductase activity (14). There is also a conserved active site (CXXC) with 
two cysteine residues, but it is unknown if this domain is required for the 
proteins’ function.  RdCVF2 expression is not restricted to the retina but also in 
the brain, testis, placentas and other tissues types (14).  However, in the 
mammalian retina, RdCVF1 is fully restricted to the eye, where it is expressed 
prominently by photoreceptor cells in a rod-dependent manner and also by bipolar 
cells in the inner retina (15).   
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Our overall hypothesis is that RdCVF1 is expressed in the rods of the 
Xenopus laevis retina; rod ablation using the XOPNTR Mtz system results in the 
loss of RdCVF1, and, as a result, cone photoreceptors subsequently degenerate 
and die. If this hypothesis is true, a Xenopus laevis RdCVF1 ortholog must be 
present in the Xenopus laevis genome, and the protein’s functional domains must 
be conserved in Xenopus and other species. Also RdCVF1 must be expressed in 
the rod photoreceptors of the Xenopus retina. 
To determine if a Xenopus laevis RdCVF1 and RdCVF2 ortholog exists, 
we used the mouse RdCVF1 and RdCVF2 as a probe, to identify RdCVF1 and 
RdCVF2 DNA and protein sequences for homologs from other species. RdCVF1 
and RdCVF2 protein sequences are present in the Xenopus genome. Xenopus 
RdCVF1is 60.6% identical to mouse RdCVF1, and Xenopus RdCVF2 is 65.2% 
identical to mouse RdCVF2. The “cap” regions of both proteins and hydrophobic 
residues are conserved in Xenopus and other species.  To determine if RdCVF1 is 
expressed in the Xenopus retina, I performed in situ hybridization using RdCVF1 
RNA probe. RdCVF1 expression was detected in the retina outer nuclear layer, 
where rods and cones are located.  
 
Materials and Methods 
RdCVF1 and RdCVF2 Sequence Comparison 
 We used the mouse RdCVF1 and RdCVF2 protein sequences as probes to 
identify RdCVF1 and RdCVF2 DNA and protein sequences for homologs 
(presumably orthologs) from species using BLAST (Basic Local Alignment 
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Search). We then aligned full-length sequences from species using the megAlign 
(DNSTAR Inc. Madison WI, USA) and ClustalW algorithm (16). Protein 
sequences from thirteen species were aligned for RdCVF1, and protein sequences 
from sixteen species were aligned for RdCVF2. RdCVF1 and RdCVF2 protein 
sequences were analyzed, and conserved functional domains in Xenopus laevis 
and other species were denoted.  
 
Phylogenetic Analysis of RdCVF1 and RdCVF2 
 RdCVF1 and RdCVF2 mRNA sequences orthologous to mouse RdCVF1 
and RdCVF2 were identified using the BLASTn genomic database. The open 
reading frame (ORF) of RdCVF1 mRNA sequences from thirteen species were 
aligned, and the ORF of sixteen RdCVF2 mRNA sequences were aligned using 
MegAlign, (DNSTAR, Inc., Madison WI, USA) ClustalW algorithm (16). Using 
this software, a phylogenetic tree was constructed, with 2000 bootstrapping trials 
to reconstruct the evolutionary history of the RdCVF protein family.   
 
Generation of Xenopus laevis Embryos 
Wild-type females were injected one week and one day prior to egg 
collection with pregnant mare's serum gonadotropin (Sigma Aldrich. St. Louis, 
MO) and human chorionic Gonadotropin (Intervet, Millsboro, DE) respectively to 
induce egg laying, and the eggs were fertilized in vitro using wild-type sperm. 
Following fertilization, eggs were sorted through and the ones undergoing proper 
divisions were selected. For the first two days, the embryos were housed in Petri 
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dishes (Fisher Scientific Inc.) with 0.1XMMR and gentamicin. On the third day, 
embryos were moved to Petri dishes containing only 0.1XMMR until the embryos 
reached Stage 41/42. Their solutions were changed once a day. Nieuwkoop and 
Faber's Normal Table for Xenopus Development was consulted for embryo 
staging (17). For the first four days, embryos were kept at 16°C. After stage 42, 
when tadpoles began to swim, they were fed in the morning with clear nettle 
supernatant and their water was changed in the late afternoon. Two weeks post 
fertilization, the tadpoles were transferred to plastic tanks containing water 
supplemented with sea salt and phosphates. 25 tadpoles were housed in each 
small tank filled approximately halfway to the top with frog water. During this 
stage, tadpoles were fed alternate days with supernatant of nettle slurry, and water 
was changed three times a week. 
 
Fixing/ Mounting Tadpoles and Cryosectioning 
Stage 56 tadpoles were euthanatized in 1% methanesulfonate (Tricaine; 
Sigma Aldrich), which was made with 50µl tricaine and 5000µl frog water 
(deionized water supplemented with Sodium Phosphate and sea salt). Tadpoles 
were placed in 100% Ethanol, fixed in 4% paraformaldehyde for 1 hour, and 
immersed in 20% sucrose for 3 hours. Tissues were mounted in OCT and uncut 
blocks were stored at -80°C.  Tadpole retina was cryostat sectioned (12µm) and 
slides were stored at -20°C. 
 
 
 13
Synthesis of DIG-labeled XlRdCVF1 RNA probe 
 Xenopus laevis RdCVF1 circular plasmid was linearized with different 
restriction enzymes, SmaI (New England BioLabs Inc.) and NotI (New England 
BioLabs Inc.). Restriction digest reaction with SmaI was set up using 64.97µl of 
Nuclease-Free water (QIAGEN Inc., USA), 10µl of NEBuffer 4 (New England 
BioLabs Inc.), 10µl of BSA (bovine serum albumin, New England BioLabs Inc.), 
11.03µl of XIRdCVF1 DNA and 4µl of SmaI enzyme. Restriction digest reaction 
with NotI was set up using 64.97µl of Nuclease-Free water, 10µl of NEBuffer 3, 
10µl of BSA, 11.03µl of XIRdCVF1 DNA and 4µl of NotI enzyme. Reactions 
were incubated for three hours at room temperature. 1µl of each sample was 
checked on 1% agarose gel (0.5g of agarose powder, 50mL of 1X TE buffer) for 
DNA linearization.  
 Digested XlRdCVF1 DNA was extracted with 100µl of Phenol: 
Chloroform and 100µl of Chloroform: Isoamyl. 10µl of 3M Sodium Acetate in 
Diethylpyrocarbonate water was then added. To precipitate the DNA, 250 µl of 
100% Ethanol was added to each sample and the tubes were placed on ice for 5 
minutes and then centrifuged at maximum speed in a 4°C microfuge (SIGMA 
labs Inc.) for 30 minutes.  Extracted DNA samples were washed with 250µl of 
75% Ethanol and vacuum dried at room temperature for 10 minutes. DNA was 
resuspended in 15µl of nuclease-free water and spectra analysis was performed 
using NanoDrop spectrophotometer (Fisher Thermo Scientific). 
 T7 RNA Polymerase-Plus (Roche no. 881 767) was used to synthesis 
antisense XlRdCVF1 probe in a reaction with the following components; 12µl 
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Nuclease-Free water, 2µl of 10x DIG-labeled mix (Roche no.1277073), 2µl 10X 
Transcription buffer, (Ambion no. AM8151G) and 1.9µl of XlRdCVF1 DNA 
digested with smaI enzyme. Sp6 RNA Polymerase -Plus (Roche no. 810274) was 
used to synthesis sense XlRdCVF1 probe in a reaction with the following 
components: 9.2µl of Nuclease-Free water, 2µl of 10x DIG-labeled mix, 2µl 10X 
Transcription buffer and 4.08µl of XlRdCVF1 DNA digested with NotI enzyme. 
Reaction was incubated for 3 hours at 37°C, then 1µl DNaseI (Thermo 
Scientific no. 89835) was added and incubated for 10 minutes at 37°C. 1µl 0.5M 
EDTA, pH 8.0 was added to stop reaction and 1µl of sample was removed to 
check on 1% agarose gel.  1.5µl LiCl, 66µl 100% Ethanol was added and tubes 
incubated at -20°C overnight for DNA precipitation. Precipitated RNA was 
centrifuged at 15,600 rcf in microfuge for 15 minutes at 4°C. Supernatant was 
poured off and 100 µl of RNF 75% Ethanol was added. Excess Ethanol was 
removed and RNA was resuspended in 20 µl Rnase Free water (QIAGEN).  RNA 
spectrophotometer analysis was performed using NanoDrop spectrophotometer 
and XlRdCVF1 RNA sense and antisense probes were resuspended in 
hybridization buffer for a final concentration 20µg/mL. 
 
In Situ Hybridization 
In situ hybridization is a technique that relies on the hybridization of a 
specific labeled nucleic acid probe with an individual cell or tissue. 
Slide Preparation 
Slides were thawed out at room temperature for 30 minutes, washed in 1X 
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PBS (5 mL 10X PBS and 54 mL water), 100% Methanol, Ptw (50 mL of 10X 
PBS, 5mL of 10% Tween-20 and 445 mL water). 
Pretreatment & Hybridization 
 PAP pen liquid blocker (Fisher Scientific no. NC972045) was used to 
label the edges of slides and Xenopus retina tissue sections were treated with 
Proteinase K for 30 seconds. Slides were washed in Glycine (100 mg Glycine and 
50 mL of Ptw), and Ptw solutions and sections were fixed in 0.2% Glutaraldehyde 
solution (8 µl Glutaraldehyde and 1 mL of 4% PFA). They were then washed in 
Ptw, sodium borohydride and in hybridization buffer. Sections were pre-
hybridized in hybridization buffer (25 mL Deionized formamide, 7.5 mL 5M 
NaCl, 5mL 10X PE, 0.5 mL 10mg/ml tRNA, 0.5mL 5% heparin, 2.5 20% SDS 
and 9 mL DEPC'd water) at 62°C for 1 hour. 100 µL of probe was added to slide 
coverslips and slides were inverted onto the coverslip with probe. XlRdCVF1 
probe synthesized with T7 Polymerase-Plus was used as the antisense 
experimental group, and XlRdCVF sense probe synthesized with Sp6 Polymerae-
Plus was used as the negative control. Slides were sealed with DPX (EMS no. 
13514) and incubated overnight at 60°C.  
Washing 
Retina tissue sections were washed in hybridization buffer for 15 minutes 
at 60°C, in washing buffer -1 (3mL 5M NaCl, 5mL 10X PE, 2.5mL 20% SDS, 
39.5mL water) at 60°C, in washing buffer-1.5 (500µl 5M NaCl, 5mL 10X PE, 250 
µL 20% SDS, 44.5mL water) at 50°C, and rinsed briefly in NTE buffer (5mL 5M 
NaCl, 500 µL 1M Tris-Cl pH 8.0, 100 µl 0.5 EDTA and 44.4 mL water). Sections 
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were washed with 100 µg/ml RnaseA in NTE (5 µL of 20mg/mL RnaseA, 995 µl 
NTE) for 45 minutes at 37°C and rinsed briefly in NTE buffer. Sections were 
washed for 15 minutes with washing buffer -2 (15 mL 100% Formamide, 1.8mL 
5M NaCl, 3 mL 10X PE, 1.5mL20% SDS and 8.7mL water) at 50°C water bath, 
in washing buffer-3 (15mL 100% Formamide, 900 µl 5M NaCl, 3mL10X PE, 300 
µl 10%-Tween-20 and 10.8mL water) for 15 minute at 50°C water bath, and in 
washing buffer-4 (5mL 5M NaCl, 5mL 10X PE, 500 µl of 10%-Tween-20 and 
39.5mL water) at room temperature for 2 minutes then at 70°C water bath for 10 
minutes. Sections were treated with IXMABT, 2mM levamisole and 2% BMBR 
(100 µL 10X MAB, 10 µl 10%-Tween-20, 2µL 1M levamisole, 200 µL 10% 
BMBR, and 688 µL water) for 30 minutes at room temperature and then treated 
with (1/2000) anti-DIG AP in 1XMABT, 2mM Levamisole and 2% BMBR (100 
µL10X MAB, 10 µl 10%-Tween-20, 2µL 1M levamisole, 200 µL 10% BMBR, 
0.5 µL anti-DIG AP and 687.5µL water) overnight at room temperature. 
 Probe Detection 
Sections were washed with 2mM levamisole 1X MABT (300 µL 10X 
MAB, 30 µL 10%-Tween-20, 6 µL 1M levamisole and 2.664mL water) for 10 
minutes, in AP Development Buffer (25µL 1M Levamisole, 500 µL 1M Tris-Cl 
pH 9.5, 100 µL 5M NaCl, 500 µL10%-Tween-20 and 3.825mLwater) for 2 
minutes. BM purple AP Substrate solution with 2mm Levamisole (I mL BM 
purple solution, 2 µL 1M Levamisole) was added to sections and slides were 
incubated at room temperature for 2 days. Sections were washed with 
PTw+EDTA and DAPI (300 µL 10X PBS, 30µL 10%-Tween-20, 6 µL of 0.5 
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EDTA, 1 µL and 6 µL water), and in Ptw and EDTA solution. FluroSave (VWR) 
with 4-Diazabicyclo [2.2.2] octane (DABCO, Sigma Aldrich) solution was added 
to slide coverslip, slides were inverted onto the coverslip and sealed slides were 
kept at -20°C. 
Microscopy  
 
Stained sections were visualized using a Leica DM600 B upright 
fluorescence light microscope with motorized Z-focusing (Leica Microsystems, 
Bannockburn, IL), fitted with a Retiga-SRV camera (Q-Imaging, Surrey, BC, 
Canada) for image capture. Images were processed using volocity software 5.0.3 
(Improvison  Inc.a PerkinaeElmer Company, Waltham, MA). 
Generation of XOPNTR Transgene and Transgenic Animals (9) 
Rene Choi from the Zuber lab generated transgenic XOP-NTR animals. 
The transgene construct pXOP(-508/+41)-NTR was generated by replacing eGFP 
of pXOP(-508/+41)GFP with the E. coli nitroreductase gene. XOPNTR F0 
transgenic Xenopus laevis were generated using restriction enzyme-mediated 
integration, and four XOPNTR founders, two males and two females, were grown 
to adulthood. 21 progeny from the founder females, XOPNTR1 and XOPNTR2, 
were generated, and only XOPNTR2 tadpoles responded to metronidazole 
treatment. 
Generation of F1 
The transgenic female was injected 1 week and one day prior to egg 
collection with pregnant mare’s serum gonadotropin (Sigma Aldrich, St. Louis, 
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MO) and human chorionic gonadotropin (Intervet, Millsboro, DE), respectively, 
to induce egg laying, and the eggs were fertilized in vitro using wild-type sperm. 
Genotyping 
Stage 50-56 XOPNTR tadpoles were tail snipped and DNA was isolated 
using DNeasy Blood & Tissue Kit (Qiagen Incorporated, Valencia, CA). 
NanoDrop spectrophotometer was used to calculate DNA concentration.  
Polymerase Chain Reaction (PCR) was set up using NTR primers, 10Mm 
DNTP'S, dimethyl sulfoxide, Nuclease Free H20, 10X Econotaq buffer and 
Econotaq enzyme. Primers specific for the transgene  
(5’ XOPNTR: 5’-CGCTAAATCCTTTGTTGCTGACGC-3’ 
 3’ XOPNTR: 5’-GTTGAACACGTAATTACCGGCAGC-3’) were used 
to identify transgenic tadpoles from their non-transgenic siblings. Gel 
electrophoresis was performed using 1% agarose gel, and transgenic animals were 
separated from their non-transgenic siblings.  
Metronidazole Treatment 
Metronidazole (Sigma Aldrich, no. M-1547) was dissolved in 0.1X MMR 
Containing 0.4% DMSO (Sigma Aldrich no. D8418) to a final concentration of 
10mM immediately before use. 4 PCR positive XOPNTR animals between stages 
50-54 were treated with Metronidazole and 4 PCR positive XOPNTR animals, 
serving as experimental control animals, were cultured in DMSO solution without 
metronidazole for 14 days. Preliminary experiments demonstrated that higher 
concentrations of metronidazole were toxic. Tadpoles were raised at 22˚C in 
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complete darkness for the indicated time because metronidazole is light sensitive. 
Solutions were changed and animals were fed alternate days. 
Immunohistochemisty 
Retina sections of Stage 56 wild type, transgenic treated and transgenic 
untreated tadpoles were washed in methanol, blocking solution containing 1X 
PBS, 0.1X Triton, 5% HIGS and water. Slides were incubated overnight in 
primary antibody, anti-Transducin polyclonal (1:100; no. Sc-389, Santa Cruz 
Biotechnology, Santa Cruz, CA) prepared in a solution containing 1X PBS, 0.1X 
Triton, 5% HIGS and water. The following day, slides were washed in 1X PBS 
solution and incubated in donkey anti-rabbit IgG Alexa 488 (1:500; no. A-21206) 
secondary antibody tagged with fluorescent molecules. The slides were mounted 
in a solution of FluorSave reagent (VWR), 2% 1,4- 
Diazabicyclo[2.2.2]octane (DABCO, Sigma Aldrich) and 10 mg/ml 4,6-
Diamidino-2-phenyindole, dilactate (DAPI, Sigma Aldrich). 
 
 
Results 
 
 As in the mammalian retina, cone cell degeneration and eventual death 
follows rod ablation in Xenopus laevis. Our hypothesis is that RdCVF1 is 
expressed in the rods of the Xenopus retina, and cone cell degeneration and death 
result from the loss of RdCVF1 following rod ablation. If this postulation is true, 
RdCVF1 protein ortholog must be present in the Xenopus genome, RdCVF1 
functional domains must be conserved among species including Xenopus, and 
RdCVF1 must be expressed in the rod photoreceptors of the Xenopus retina.  
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Figure 4. 
Sequence Conservation of RdCVF1 Proteins 
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Figure 4 shows the multiple alignments of existing and 
predicted RdCVF1 full -length proteins. (GenBank 
Accession numbers for these sequences can be found in 
appendix A). Organism names of each protein sequence 
are listed on the left and predicted sequences are denoted 
(_P). Percent identity of species RdCVF1 to the mouse 
RdCVF1 and RdCVF2 is listed at the bottom panel. 
Residues identical in all species are highlighted in yellow, 
hydrophobic residues (A,C,E, F,G,I,L,M,S,T,V,W,Y) are 
marked with black triangles. Catalytic (CXXC) sites are 
shown (red arrow) and the red box around the residues, 
blue arrow represents the beginning of the “cap” region.  
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Figure 5. 
Sequence Conservation of RdCVF2 proteins 
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Figure 5 shows the multiple alignments of existing and 
predicted RdCVF2 full-length proteins. (GenBank Accession 
numbers for these sequences can be found in the appendix B). 
Organism names of each protein sequence are listed on the left 
and predicted sequences are denoted (_P). Percent identity of 
species RdCVF2 to the mouse RdCVF1 and RdCVF2 is listed 
at the bottom (right). Residues identical in all species are 
highlighted in yellow, and hydrophobic residues (A,C,E, 
F,G,I,L,M,S,T,V,W,Y) are marked with black triangles. 
Catalytic (CXXC) sites are shown (the red arrow) and the red 
box around the residues, and the blue arrow represents the 
beginning of the “cap” region.  
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Analysis of RdCVF1 and RdCVF2 Protein Sequence 
 Chamel and colleagues (14) identified RdCVF2, another bifunctional 
protein belonging to the Rod-derived Cone Viability Factor family. This isoform 
shares many similarities with RdCVF1 in terms of the gene structure. I asked 
whether RdCVF1 and RdCVF2, and in particular the domains of the proteins 
required for their function, are conserved among species, especially in Xenopus. I 
used the mouse RdCVF1 and RdCVF2 protein sequences as probes to identify 
RdCVF1 and RdCVF2 DNA and protein sequences for homologs (presumably 
orthologs) from species using BLAST. I then used the program megAlign 
(DNASTAR, Madison WI .USA) and ClustalW algorithm (16) to align the 
sequence and determine if functional domains are conserved in Xenopus. Only 
full-length sequences were used. Protein sequences from thirteen species were 
aligned for RdCVF1 and protein sequences from sixteen species were aligned for 
RdCVF2. 
  RdCVF1 aligned protein sequence (Figure 4) showed conserved active 
sites (CXXC) with two distinct cysteine residues in all species except Xenopus 
laevis, Xenopus Tropicalis and Zebrafish. This site confers a thiol-reductase 
activity on RdCVF1 (14). In Xenopus, the first cysteine is replaced by a serine. A 
conserved “cap” region is present in all the species. The “cap” is the C-terminal 
region present in RdCVF1/2-L but absent in RdCVF1/2-S. This portion of the 
protein gives RdCVF1/2-L a putative thio-oxyreductase activity (14). 
Hydrophobic residues (A,C,F,G,I,L,M,S,T,V,W,Y) are conserved in all the 
species. This hydrophobic patch is more prevalent in the sequences before the 
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“cap” region and it is where RdCVF1and RdCVF2 interact with other proteins or 
cell membrane structures (14). RdCVF2 aligned protein sequences (Figure 5) 
have conserved active sites (CXXC) with two distinct cysteine residues in all 
species. There is also a “cap” region in all species and hydrophobic resides are 
also conserved.  
 I conclude that RdCVF1 and RdCVF2 are present in the Xenopus genome. 
In Xenopus RdCVF1, the first cysteine residue at the catalytic site is not 
conserved. Instead of CXXC, serine has replaced the first cysteine making the 
active site SXXC. The “cap” region and hydrophobic residues are found in 
Xenopus.  
Conservation of RdCVF1 Gene Structure 
 Cone viability is dependent on the production of RdCVF1-S form. In 
mouse, this isoform is generated by the presence of a stop codon at the end of the 
first exon of RdCVF1 and RdCVF2 (14). To evaluate if this stop codon is present, 
we aligned RdCVF1 gDNA, mRNA and protein of Xenopus and mouse. Xenopus 
laevis genome was provided by Richard Harlands lab (University of California, 
Berkeley), and Reyna Martinez from the Zuber lab blasted the genome to obtain 
Xenopus RdCVF1 genomic DNA. The stop codon at the end of the first exon is 
strictly conserved in mouse and Xenopus (figure 6). This observation does not 
prove that RdCVF1-S exists in Xenopus but implies a possible existence. 
GenBank Expressed Sequence Tag databases were searched for RdCVF1/2 short 
isoforms, and I was unable to find any EST’s. From this result, I conclude that 
RdCVF1-S isoform could be present in Xenopus laevis.  
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Mouse_DNA														GAA	CTG	AGG	AGG	TGA	GGC	CCC	
		
X.	laevis	_DNA										GAA	TTC		AGG	AGG		TGA	GAT	AGG	
		
Mouse_mRNA										GGU	GCG	GCU	AGG	UGA	GAC	CUC	
		
X.	laevis_	mRNA							ACA	AAA	UUU	UGG	UGA	AAA	AUA	
		
Mouse_	A.A																			E						L						R						R				*								D					L	
		
X.	laevis	_A.A																	E					F						R						R							*								D			R	
		
 
Figure 6.  
Conservation of Xenopus and Mouse RdCVF1 Stop Codon. 
 Mouse and Xenopus DNA, mRNA and amino acid sequences are aligned. 
Organism name is listed (left). The genomic region surrounding the stop codon at 
the end of the first coding exons of mouse and Xenopus RdCVF1 are aligned. 
Conserved stop codons are colored in red. (GenBank Accession numbers are 
listed on appendix D). 
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Figure 7.  
Phylogenetic Tree of RdCVF Family.  
Figure 7 shows the evolutionary relationship of RdCVF1 and RdCVF2. Organisms 
are grouped in their respective classes. RdCVF1 species are grouped together at 
the bottom and RdCVF2 species are grouped together at the top. The arrow points 
to the Xenopus laevis RdCVF1 I use in the lab. (GenBank Accession numbers are 
listed on appendices C and D). 
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Phylogenetic Analysis of RdCVF1 and RdCVF2  
 Chamel and colleagues identified a protein paralogous to RdCVF1 in 
mouse, RdCVF2. Both have similar protein sequences and gene structures are 
highly similar. It is shown that the degree of homology between RdCVF1 and 
RdCVF2 is 58.0% for the long isoforms and 53.5% for the short isoforms (14). It 
is important to reconstruct evolutionary history of the RdCVF family to determine 
if the RdCVF sequence used in our lab is RdCVF1. mRNA sequences orthologous 
to mouse RdCVF1 and RdCVF2 were identified using the BLASTn genomic 
database. The open reading frame (ORF) of RdCVF1 mRNA sequences from 
thirteen species were aligned and sixteen ORF of RdCVF2 mRNA were aligned 
using MegAlign (DNASTAR, Madison, WI USA), CrustalW algorithm (16) and 
the software was used to construct a phylogenetic tree.  
 RdCVF1 sequences grouped together on the phylogenetic tree away from 
RdCVF2 group (Figure 7). For all the species aligned, RdCVF1 sequence 
similarity as compared to the mouse RdCVF1 (Figure 4) ranged from 45.6% 
(cichlid fish) to 82.4% (elephant). The sequence similarity of all species aligned 
RdCVF1 sequence compared to the mouse RdCVF2 ranged from 27.6% (Xenopus 
laevis) to 34.0% (wild-turkey). The Xenopus laevis RdCVF that we have in the 
lab is 53.5% similar to mouse RdCVF1 and only 27.6% similar to mouse 
RdCVF2. From these results, I conclude that the Xenopus laevis RdCVF we use 
in the lab is most likely the Xenopus laevis ortholog. 
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Expression Pattern of Xenopus laevis RdCVF1 
 In the mouse Retinitis Pigmentosa model, RdCVF1 protein expression is 
rod dependent and mainly expressed in the Outer Nuclear Layer (ONL) of the 
retina. Also, Reichman and colleagues (18) demonstrated that RdCVF1 is 
expressed slightly in the Inner Nuclear Layer (INL), specifically in bipolar cells. 
If RdCVF1 is present in our Xenopus model, then it should be expressed similarly. 
I prepared RdCVF1 probe and performed in situ hybridization to examine the 
expression pattern. 
 
 30
Figure 8a.  
Circular plasmid of Xenopus laevis RdCVF1 (XlRdCVF1). This 
figure represents the plasmid that was linearized to synthesize 
XlRdCVF1 probe. NotI and SmaI restriction sites are indicated. 
The open reading frame of the DNA is marked (blue arrow). The 
Sp6 forward promoter and T7 reverse promoter are also shown.  
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Figure 8b.  
Gel Electrophoresis Analysis of Linearized XlRdCVF.  
Lane 1, 10 kb ladder; lane 2, XlRdCVF digested with NotI enzyme; lane 3, 
XlRdCVF1 digested with SmaI enzyme; lane 4, undigested XlRdCVF1. 
Undigested plasmid size is about 5 kb. 
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Sample ID ng/µl A260 A280 260/280 
M100 Not 1 
Sp6 
352.88 8.82 4.38 2.02 
M100 Sma1 
T7 
617.25 15.43 7.6 2.03 
Figure 8c.  
Spectra Analysis of Xenopus RdCVF1 Probe. Probe concentration was (ng/µl) 
calculated using NanoDrop spectrophotometer. RNA has absorption at 260 nm. 
The ratio of absorbance at 260 nm, and 280 nm is used to assess the purity of 
RNA.  
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Figure 8d.  
Gel Electrophoresis Analysis of XLRdCVF1 Probe. Lane 1, 10 kb ladder; lane 
2, anti-sense XLRdCVF1 probe synthesized with T7 RNA Polymerase-Plus; Lane 
3, sense XlRdCVF1 probe synthesized with Sp6 RNA Polymerase-Plus.  
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Probe Preparation 
 Xenopus laevis RdCVF1 circular plasmid (Figure 8a) was linearized by 
restriction enzyme digest using Sma1 and Not1 restriction enzymes (Figure 8b). I 
extracted the linearized DNA by Phenol: Chloroform extraction. XlRdCVF-NotI 
DNA, transcription buffer, DIG-labeling mix and Sp6 RNA Polymerase -Plus 
were used to synthesize RdCVF1 sense probe. XlRdCVF1-SmaI DNA and T7 
RNA Polymerase- Plus were used to synthesize RdCVF1 anti-sense probe. The 
probe concentration and purity was analyzed (Figure 8c), using a Nanodrop 
spectrophotometer (Thermo Fisher Scientific Inc. USA ), and I also checked the 
purity of the probe on agarose gel (Figure 9d). 2.02 and 2.03 260/280 indicated 
that the probe didn’t have any protein contamination. The probes were 
resuspended in hybridization buffer.  
 
In Situ Hybridization  
 In situ hybridization uses a labeled a complementary DNA or RNA strand 
such as a probe to localize a specific DNA or RNA sequence in a tissue. I used a 
DIG-labeled anti-sense XLRdCVF probe to localize the expression of RdCVF1 in 
the Xenopus retina. A DIG-labeled sense XLRdCVF probe was used as a control. 
In retina tissue stained with the anti-sense probe, RdCVF1 expression was 
localized in the outer nuclear layer of the Xenopus retina where rod and cone 
photoreceptors are located. I also observed a slight expression in the Inner nuclear 
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layer (Figure 10, panels A and A’’). Retina stained with sense probe (Figure 10, 
panels C and C’’), RdCVF expression was not detected in the retina. The nucleus 
of all retina sections was stained with DAPI. Results from the In situ 
hybridization experiment conclude that RdCVF1 is expressed in the outer nuclear 
layer and also possibly in the inner nuclear layer of the Xenopus retina.  
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Figure 9.  
In situ Localization of Xenopus RdCVF1: Antisense Probe.   
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Figure 9 shows In Situ hybridization results using XLRdCVF 
anti- sense probe (Panels A-A”). RdCVF1 expression is the 
purple staining (arrow on panel A”) on panels (A) and (A”).  
Panel   (A) was taken with 10X magnification and A’’ had 
20X magnification. The retina Outer Nuclear Layer (ONL), 
Inner Nuclear Layer (INL), Ganglion Cell Layer (GCL), and 
lens (L) are indicated.  Panel (B) shows the section of the 
retina stained with DAPI (blue) in 10X magnification and 
panel (B”) is 20X magnification of retina section stained 
with DAPI.  
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Figure 10. 
In Situ Localization of Xenopus RdCVF1: Sense Probe 
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Figure 10 shows In Situ hybridization results using a XLRdCVF 
sense probe (Panels A-A”) RdCVF1 expression is not detected, 
and purple staining was not observed (arrow on panel A”) on 
panels (A) and (A”).  Panel  (A) was taken with 10X 
magnification and A’’ had 20X magnification. The retina outer 
nuclear layer (ONL), Inner Nuclear Layer (INL), Ganglion Cell 
Layer (GCL) and lens (L) are indicated.  Panel (B) shows the 
section of the retina stained with DAPI (blue) in 10X 
magnification, and panel (B”) is 20X magnification of retina 
section stained with DAPI. 
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XOPNTR-Rod Ablation System 
 In situ hybridization detected RdCVF1 expression in the Xenopus laevis 
retina. This result is consistent with the hypothesis that RdCVF1 is expressed in 
the Xenopus retina in a rod dependent manner. Rene Choi from the Zuber lab 
generated transgenic Xenopus laevis expressing the Escherichia coli enzyme 
nitroreductase (NTR) in retinal outer nuclear layer, under the control of a rod-
specific rhodopsin (XOP) promoter (Figure 11a). Treating transgenic animals 
with metronidazole resulted in complete ablation of rod photoreceptors on the 
12th day of treatment. I decided to test this rod-ablation system for two purposes: 
to test whether RdCVF1 expression will be lost in XOPNTR metronidazole 
treated animals, and also to determine if RdCVF1 is only expressed in rods of the 
retina outer nuclear layer. I performed PCR to identify transgenic tadpoles using 
primers specific for the transgene (Figure 11b for PCR results).  
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Figure 11a.  
Circular plasmid of XOP-NTR System. This figure shows the Xenopus laevis 
rhodopsin promoter driving the expression of E. coli nitroreductase enzyme. 
Forward and reverse primers are denoted (red triangles,) and the open reading 
frame of the DNA is shown (black arrow). 
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Figure 11b.  
PCR Identification of Transgenic Xenopus laevis Tadpoles. 
Lane 1, 10 kb ladder; lane 2, +control (white arrow); lane 3, -
control (white arrow); lanes 4-25, DNA samples extracted from 
tadpoles. Circled bands indicate PCR positive animals.  
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Immunohistochemistry 
 After identifying transgenic tadpoles, wild type and transgenic tadpoles 
were treated with metronidazole for 10 days. At the same time, a group of 
transgenic tadpoles was left untreated (placed in DMSO solution) for ten days. I 
sectioned the retina of these tadpoles and performed immunohistochemistry using 
anti-Transducin polyclonal (1:100; product # Sc-389, Santa Cruz Biotechnology, 
Santa Cruz, CA). All the sections were also stained with DAPI to label the nuclei. 
Wild type, metronidazole treated animals had their retina outer segments intact 
after 10 days of treatment (Figure 12). Transgenic animals that did not receive 
treatment also didn’t exhibit any loss of retina outer segments (Figure 13). On the 
hand, transgenic animals that were treated with metronidazole showed outer retina 
outer segment degeneration (Figure 14). These results confirmed that the lab’s 
XOPNTR- rod ablation system is working. In future experiments, we will 
examine the effect of rod ablation on Xenopus laevis RdCVF1 expression and also 
determine if RdCVF1 is only expressed by rods in the retinal outer nuclear layer.  
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Figure 12.  
Transducin Staining of Wild Type Xenopus laevis Treated with 
Metronidazole.  
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Figure 13.  
Transducin Staining of Untreated XOPNTR Xenopus laevis 
Panel (A) is a 10X magnification of retina section of treated wild 
type animals. The lens is labeled (L). Panel (B) is 20X 
magnification of the same retina section and the arrow point to 
the retina outer segment. Panels (B) and (B”) are the same retina 
sections stained with transducin and panels (C) and  (C”) are the 
same retina sections stained with DAPI.  
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Panel (A) is a 10X magnification of retina section of treated wild type 
animals. The lens is labeled (L). Panel (B) is 20X magnification of the same 
retina section and the arrow point to the retina outer segment. Panels (B) 
and (B”) are the same retina sections stained with transducin and panels (C) 
and  (C”) are the same retina sections stained with DAPI.  
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Figure 14.  
Transducin Staining of XOPNTR Xenopus laevis Treated with 
Metronidazole.  
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Discussion 
Panel (A) is a 10X magnification of retina section of treated 
wild type animals. The lens is labeled (L). Panel (B) is 20X 
magnification of a different retina section and the arrow point 
to the retina outer segment. Panels (B) and (B”) are the 
different retina sections stained with transducin and panels (C) 
and  (C”) are the different retina sections stained with DAPI.  
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 As in the mammalian retina, cone degeneration and eventual cell death 
follows rod ablation in Xenopus laevis. I hypothesized that the protein RdCVF1 is 
expressed in the rods of Xenopus retina and cone degeneration and cell death 
result from the loss of RdCVF1 expression. I report that RdCVF1 ortholog exist 
in the Xenopus genome, and most of RdCVF1 functional domains are conserved 
in Xenopus and other species. Also, RdCVF1 is expressed in the outer nuclear 
layer of the Xenopus retina and potentially in the inner nuclear layer.   
Conservation of Xenopus laevis RdCVF1 
 Xenopus laevis RdCVF1 amino acid sequence, just like the mouse 
RdCVF1 sequence, has a conserved “cap region” and hydrophobic residues that 
are more prevalent in regions before the “cap.” However, unlike the mouse 
sequence, Xenopus RdCVF1 doesn’t have the catalytic (CXXC) region with two 
distinct residues. Instead Xenopus RdCVF1 has (SXX), a cysteine to serine 
substitution. Although it is proposed that this sequence region confers thiol-
reductase activity on RdCVF1 (14), it is unclear if the CXXC region is required 
for RdCVF1 protein function. In order to determine the importance of this 
catalytic site, we will need to design an experiment to rescue cone degeneration 
after rod ablation by expressing RdCVF1 in a rod-less Xenopus retina. If we are 
not able to stop cone death while expressing RdCVF1 in the absence of rods, then 
it may be possible that the cysteine to serine base substitution might be critical to 
the protein function. Results from the experiment will determine if CXXC region 
is vital for RdCVF1 protein function. If it is this, we can change the serine to a 
cysteine at the catalytic site.  
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 Chalmel and colleagues (14) showed that in mouse cone viability is 
dependent on the production of the RdCVF1-S, and this isoform is generated by 
the presence of a stop codon at the end of the first exon of RdCVF1. In Xenopus 
RdCVF1 genomic DNA, there is also a stop codon at the end of the first exon. 
However, this does not prove that RdCVF1-S exists in Xenopus. To confirm that 
RdCVF-S is present in the Xenopus retina, we can design an experiment to test 
specifically for this isoform. We can generate probes that only detect RdCVF1 
and perform in situ experiments to determine whether there is an RdCVF1 
expression. We can generate this probe by isolating RNA and performing PCR to 
amplify the 3’UTR region of RdCVF1. We can also make primers that will only 
amplify the region of RdCVF1 gene known to be present in the short isoform 
only. It is important to determine if RdCVF1-S is present in Xenopus retina 
because this isoform is the cone trophic factor.  
 
Expression Pattern of Xenopus laevis RdCVF1 
 The In situ hybridization experiment localized RdCVF1 expression in the 
outer nuclear layer of the Xenopus retina, where rods and cones are located. I also 
observed a light expression in the inner nuclear layer. Although I know that 
RdCVF1 is expressed in the Xenopus retina, my result does not indicate the 
specific retina cell type that expresses the protein. To determine whether rods or 
other retinal cell types are expressing RdCVF1, we can perform in situ 
hybridization using a XlRdCVF1 RNA probe and use cell specific markers to 
label rods, cones and bipolar cells. Also, we can test the loss of RdCVF1 
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expression in the retina of transgenic XOPNTR metronidazole treated animals by 
performing in situ hybridization on retina sections of untreated XOPNTR and 
treated XOPNTR animals to detect the levels of RdCVF1 expression. Cones could 
be labeled with calbindin to detect the loss of cones in the rod-ablated retina. We 
expect undetected RdCVF1 expression in the outer nuclear layer of XOPNTR 
treated, since rods are ablated, and also we expect to see fewer cone cells in that 
retina.  
 Our hypothesis that RdCVF1 is expressed in the rods and the loss of 
RdCVF1 in the Xenopus retina leads to cone death could be further tested by 
knocking down RdCVF1 in the rods of Xenopus retina without ablating rods to 
determine if cones will degenerate. However, there isn’t a good technique that 
could be used to turn gene expression on and off in Xenopus laevis later on in 
development. Therefore, the best way to determine the effect of RdCVF1 
expression on cone viability is to develop double transgenic Xenopus animals 
expressing the E. coli nitroreductase enzyme and RdCVF1. This model will 
provide an opportunity to treat XOPNTR-RdCVF1 animals with metronidazole to 
ablate rods and at the same time see if the over-expression of RdCVF1 will delay 
or even inhibit cone death.  
 In this thesis, I report that RdCVF1 is present in the Xenopus and the 
functional domains of the proteins required for its function are conserved. Also, 
RdCVF1 is expressed in the Xenopus retina and using the Zuber lab XOPNTR 
model; it could be determined whether RdCVF1 can ultimately save cone death. 
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Further findings from this project could present a unique therapeutic avenue for 
patients suffering from Retinitis Pigmentosa. 
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Appendix A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RdCVF1 Amino Acid Sequences 
 
   Species  
 
GenBank Accession Numbers 
 
 Xenopus laevis   
Xenopus Tropicalis  
Mouse 
Human 
Zebrafish  
Elephant  
Dog   
Pig  
Cattle   
Rhesus monkey  
Wild Turkey  
Arboreal Lizard   
Cichlid fish  
 
NP_001087547 
XP_002935469 
NP_663573  
NP_612463 
XP_696316 
XP_003413320 
XP_541952 
XP_003354188 
XP_612296 
XP_001113624 
XP_003213896 
XP_003223253 
XP_003450058 
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Appendix B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
    
 
 
  Amino Acid Sequences 
 
   Species  
 
GenBank Accession Numbers 
 
 Xenopus laevis  
Xenopus Tropicalis  
Mouse  
Brown Rat  
Human  
Cattle  
Rabbit  
Pike   
Guinea Pig  
Gibbon  
Chimpanzee  
Opossum  
Arboreal Lizard 
 Chicken  
Zebra Finch  
Cichlid Fish  
NP_001085382 
XP_002937068 
NP_083449 
NP_001163900 
NP_001155097 
NP_001179622 
XP_002708327 
ACO13774 
XP_003461886 
XP_003279088 
XP_520116 
XP_001376146 
XP_003216546 
XP_003643062 
XP_002190446 
XP_003451530 
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Appendix C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              RdCVF1 mRNA Sequences 
 
   Species  
 
GenBank Accession Numbers 
 
Arboreal Lizard   
Cattle   
Cichlid Fish  
Dog  
Elephant  
Human   
Mouse  
Pig  
Rhesus Monkey  
Wild Turkey  
Xenopus laevis  
Xenopus Tropicalis   
Zebra Fish  
XM_003223205 
XM_612296 
XM_003450010 
XM_541952 
XM_003413272 
NM_138454 
NM_145598  
XM_003354140 
XM_001113624 
XM_003213848 
NM_001094078 
XM_002935423 
XM_691224 
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RdCVF2 mRNA Sequences 
 
   Species  
 
GenBank Accession Numbers 
 
Arboreal Lizard   
Brown Rat  
Cattle  
Chicken   
Chimpanzee  
Cichlid Fish  
Gibbon  
Guinea Pig  
Human   
Mouse  
Opossum  
Pike  
Rabbit    
Zebra Finch  
Xenopus laevis  
Xenopus Tropicalis  
 
XM_003216498 
NM_001170429 
NM_001192693 
XM_003643014 
XM_520116 
XM_003451482 
XM_003279040 
XM_003461838 
NM_001161625 
NM_029173 
XM_001376109 
BT079350 
XM_002708281 
XM_002190410 
NM_001091913 
XM_002937022 
Mouse genomic DNA: 
NCBIM37:8:74084455:74090548:1 
 
Xenopus laevis Genomic DNA: 
Scaffold160012 
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Capstone Summary 
In the United States alone, more than one million people are blind. One of 
the leading causes of blindness is Retinitis Pigmentosa (RP). RP is a group of 
inherited disorders that results from the death of photoreceptor cells and leads to 
the decline of vision. Approximately 100,000 people in the United States and 1.5 
people worldwide are affected by Retinitis Pigmentosa. Currently, there is no 
cure.  
 The human retina is the light sensitive tissue lining the inner surface of the 
eye. The retina has many cells including the two types of photoreceptors, rods and 
cones. Rods are very sensitive to low light conditions, and are responsible for 
vision under low light conditions and also periphery vision. Rods are concentrated 
on the outer edges of the retina, and on average there are about 90 million rods in 
the retina. On the other hand, cones require more light for functioning, and they 
provide information about color in a very sharp detail. Cone cells are concentrated 
around the retina’s center. On average there are about 4.5 million cone cells in the 
retina. Rod cell death results in night-blindness, leaving daylight vision intact. 
 Much more devastating to patients is the subsequent death of the cone 
photoreceptors. Although cones represent no more than 5% of all photoreceptors 
in the human eye, their role in vision is crucial. Cones are required for color 
vision, and their death leads to daylight vision loss and ultimately complete 
blindness. Uncoupling the cellular and molecular mechanisms that link rod cell 
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loss to cone death would allow cones to survive and patients afflicted with 
Retinitis Pigmentosa to retain functional vision. 
The progressive loss of cones following the initial rapid period of rod 
photoreceptor death raises the possibility of rod-cone interactions playing a vital 
role in photoreceptor development and survival. Understanding why rod death 
leads to cone death is crucial. I hypothesized that rods produce some kind of 
signal essential for maintaining cone viability, and the disappearance of rods 
deprive cones of this signal and trigger their degeneration. This factor is a protein 
known as Rod-derived Cone viability factor 1 (RdCVF1), a protein known to 
maintain the function and viability of cone photoreceptor cells in the retina. 
Nucleoredoxin like1 (Nxnl1) gene, a protein involved in defense mechanism 
against oxidative stress, encodes RdCVF1.  In mouse, there is a long form 
(RdCVF1-L) and a short form  (RdCVF1-S). There is also a similar protein, 
RdCVF2, that also has both long and short forms. RdCVF2 expression is not 
restricted to the retina but also in the brain, testis, placentas and other tissue types. 
However, RdCVF1 is only expressed in the retina and it is the protein I explore in 
this project.  
In order to explore the importance of RdCVF1 to cone survival in our lab, 
we needed a model organism. Our lab chose the tadpoles of the African Clawed 
frog, Xenopus laevis, because Xenopus has been used in the field of 
developmental biology for long time and wide variety of molecular biology 
techniques have been developed for this model organism. Also, many of the genes 
have been identified. And it is easy to obtain and maintain large numbers of 
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Xenopus tadpoles in the laboratory. Our lab recently developed a model of 
Retinitis Pigmentosa in the African Clawed Frog, Xenopus laevis, to examine 
whether Xenopus laevis will exhibit the same secondary cellular changes after rod 
ablation. To answer this question, Rene Choi generated a transgenic line of 
Xenopus laevis, driving the expression of E. coli nitroreductase (NTR) under the 
control of the rod-specific rhodopsin promoter (XOP).  Nitroreductase converts 
nitromidazole prodrugs, such as metronidazole (Mtz), into a cytotoxic DNA cross 
linker. Using this drug, we demonstrated that rods were dying during 
metronidazole treatment.  
Based on the aforementioned observation, I hypothesized that that 
RdCVF1 is expressed in the rods of the Xenopus laevis retina. Rod ablation using 
our model system results in the loss of RdCVF1, and, as a result, cone 
photoreceptors subsequently degenerate and die. If this hypothesis is true, a 
Xenopus laevis RdCVF1 ortholog must be present in the Xenopus laevis genome, 
and the protein’s functional domains must be conserved in Xenopus and other 
species. Also RdCVF1 must be expressed in the rod photoreceptors of the 
Xenopus retina. 
To determine if a Xenopus laevis RdCVF1 and RdCVF2 ortholog exists, I 
used the mouse RdCVF1 and RdCVF2 as a probe, to identify RdCVF1 and 
RdCVF2 DNA and protein sequences for homologs in Xenopus and other species. 
I found that RdCVF1 and RdCVF2 protein sequences are present in the Xenopus 
genome, Xenopus RdCVF1is 60.6% identical to mouse RdCVF1 and Xenopus 
RdCVF2 is 65.2% identical to mouse RdCVF2. The proteins’ functional domains 
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such as the “cap” regions and hydrophobic residues are conserved in Xenopus and 
other species. The “cap” is a region that is present in the long forms of the 
proteins but absent in the short forms. Since there are both RdCVF1 and 
RdCVF2, I needed to confirm that the protein I used in the lab was indeed 
RdCVF.  To do that, I used computer software to generate a phylogenetic tree of 
RdCVF1 and RdCVF2 using mRNA sequences. I found that RdCVF1 and 
RdCVF2 grouped separately, and the Xenopus laevis RdCVF1 in our lab grouped 
with other RdCVF1 sequences, indicating that the protein I used in the lab is most 
likely RdCVF1.  
After determining that RdCVF1 exists in our model organism, I performed 
in situ hybridization to detect the protein expression. In situ hybridization uses a 
labeled complementary DNA or RNA strand as a probe to localize a specific 
DNA or RNA sequence in a tissue. I used the Xenopus RNA RdCVF1 probe to 
find where the protein is expressed the retina. Expression was detected in the 
outer nuclear layer of the retina, where rods and cones are located, supporting the 
postulation that RdCVF1 is secreted by rods.  
In this thesis, I report that RdCVF1 is present in the Xenopus and the 
functional domains of the proteins required for its function are conserved. Also, 
RdCVF1 is expressed in the Xenopus retina and using the Zuber lab XOPNTR 
model; it could be determined whether RdCVF1 can ultimately save cone death. 
Further findings from this project could present a unique therapeutic avenue for 
patients suffering from Retinitis Pigmentosa.  
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